Dienogest Versus Luteal Phase Fluoxetine in the Management of Premenstrual Syndrome: A Randomized Double Blind Placebo Controlled Trial
Phase of Trial: Phase III
Latest Information Update: 02 Feb 2017
At a glance
- Drugs Dienogest (Primary) ; Fluoxetine
- Indications Premenstrual syndrome
- Focus Therapeutic Use
- 20 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 20 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 30 Apr 2015 New trial record